Contrarius Group Holdings Ltd
Position in NTLA — Intellia Therapeutics, Inc.
CIK 2054801
Hamilton, D0
Position in NTLA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$33,082,457
+$8,572,682 QoQ
Shares Held
1,955,228
+2.3% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
1.52%
of 13F equity value
Holder Rank
#19
of 330 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Contrarius Group Holdings Ltd holds $88,493,401 across 2 Biotechnology names. NTLA ranks #2 (37.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BEAM |
Beam Therapeutics Inc.
|
1,614,538 | $55,410,944 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
This page
|
1,955,228 | $33,082,457 |
All Filings in NTLA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,082,457 | 1,955,228 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $24,509,775 | 1,911,839 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,423,175 | 714,480 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $101,719,194 | 5,889,936 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $14,562,525 | 1,552,508 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $14,369,594 | 2,021,040 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $11,798,322 | 1,011,863 | Shares | Defined | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||